Standard InChI: InChI=1S/C24H26N2O5/c1-26-14-17(11-15-7-8-16(23(27)28)12-22(15)30-2)20-13-18(9-10-21(20)26)25-24(29)31-19-5-3-4-6-19/h7-10,12-14,19H,3-6,11H2,1-2H3,(H,25,29)(H,27,28)
1.Matassa VG, Maduskuie TP, Shapiro HS, Hesp B, Snyder DW, Aharony D, Krell RD, Keith RA.. (1990) Evolution of a series of peptidoleukotriene antagonists: synthesis and structure/activity relationships of 1,3,5-substituted indoles and indazoles., 33 (6):[PMID:2342072][10.1021/jm00168a037]
2.Brown FJ, Cronk LA, Aharony D, Snyder DW.. (1992) 1,3,6-trisubstituted indoles as peptidoleukotriene antagonists: benefits of a second, polar, pyrrole substituent., 35 (13):[PMID:1320123][10.1021/jm00091a010]
3.Proschak E, Heitel P, Kalinowsky L, Merk D.. (2017) Opportunities and Challenges for Fatty Acid Mimetics in Drug Discovery., 60 (13):[PMID:28252961][10.1021/acs.jmedchem.6b01287]